Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabin IPV Phase 2 in Infants
NCT01056705Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jul 2009
- Primary completion
- May 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Inactivated poliovirus vaccine (Sabin strain) in poliomyelitis (5 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoints: Safety of Inactivated Poliomyelitis Vaccine at 1 year and Immunogenicity of Inactivated Poliomyelitis Vaccine at 1 year. Started Jul 2009; status: completed.
02
Drugs
Inactivated poliovirus vaccine (Sabin strain)
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT01056705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056705.